Rigel Pharmaceuticals RIGL Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's convertible preferred stock outstanding shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's convertible preferred stock outstanding shares?
- Rigel Pharmaceuticals (RIGL) reported convertible preferred stock outstanding shares of 0 in Q4 2025.
- What does convertible preferred stock outstanding shares mean?
- This represents the total number of shares of preferred stock that can be converted into common equity at the holder's option. It is a critical component of the company's capital structure that may lead to future dilution of existing common shareholders. Tracking this helps investors understand the potential impact on earnings per share and voting control.